Sterling Capital Management’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.81K Sell
600
-424
-41% -$4.83K ﹤0.01% 2356
2026
Q1
$11.6K Sell
1,024
-796
-44% -$8.63K ﹤0.01% 2292
2025
Q4
$23.4K Sell
1,820
-288
-14% -$3.56K ﹤0.01% 2141
2025
Q3
$23.5K Buy
2,108
+1,270
+152% +$12.3K ﹤0.01% 2073
2025
Q2
$8.31K Buy
838
+170
+25% +$1.66K ﹤0.01% 2244
2025
Q1
$6.27K Sell
668
-553
-45% -$5.81K ﹤0.01% 2043
2024
Q4
$11.2K Buy
1,221
+1,100
+909% +$8.09K ﹤0.01% 2112
2024
Q3
$941 Buy
+121
New +$874 ﹤0.01% 2561
2018
Q2
Sell
-37,524
Closed -$647K 841
2018
Q1
$647K Hold
37,524
0.01% 729
2017
Q4
$624K Hold
37,524
0.01% 738
2017
Q3
$641K Hold
37,524
0.01% 736
2017
Q2
$608K Hold
37,524
0.01% 756
2017
Q1
$651K Buy
+37,524
New +$627K 0.01% 751

Other funds holding ANGO

Sterling Capital Management's ANGO Position: Q2 2026 in Review

Sterling Capital Management reduced its AngioDynamics (ANGO) stake by 41% in Q2 2026, selling an estimated $4.83K and leaving 600 shares worth $7.81K. The position accounts for ﹤0.01% of the portfolio, ranked #2356.

Sterling Capital Management first reported a position in ANGO in Q1 2017 and has held it in 13 quarters since. The position peaked at $651K in Q1 2017. 162 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Sterling Capital Management held 600 shares of AngioDynamics worth $7.81K as of Q2 2026.
  • Sterling Capital Management sold 424 AngioDynamics shares in Q2 2026, an estimated $4.83K.
  • AngioDynamics made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2356 holding.
  • Sterling Capital Management first reported a position in AngioDynamics in Q1 2017 and has held it in 13 quarters since.
  • Sterling Capital Management's AngioDynamics position peaked at $651K in Q1 2017.
  • 162 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.